[Indications of automatic ventricular implantable defibrillator. Implications for daily practice].
The authors were the redactors of the Guidelines of the French Society of Cardiology for the indications of the automatic implantable defibillator, derived from the available indication in USA, and from the ulteriorly performed controlled studies. Three Class-I indications were selected: 1) circulatory arrest due to ventricular tachycardia (VT) or fibrillation (VF) whithout acute curable aetiology. 2) sustained VT with underlying heart disease and contractile alterations. 3) non-sustained VT with prior myocardial infarction and LVEF < 35% with inductible despite maximal drug therapy. Class-II indications were also three: 1) inheritable disease with high risk of sudden death without known effective therapy. 2) Syncope in patients with underlying heart disease and inductible VT or VF during electrophysiologic study. 3) VT or VF in patients in list for heart transplant.
Leclercq
J F
JF
Centre médicochirurgical de Parly 2, département de rythmologie interventionnelle, 21, rue Moxouris, 78150 Le Chesnay, France.
D000328:Adult; D018849:Controlled Clinical Trials as Topic; D003645:Death, Sudden; D017147:Defibrillators, Implantable; D006801:Humans; D008297:Male; D008875:Middle Aged; D017410:Practice Guidelines as Topic; D013577:Syndrome; D017180:Tachycardia, Ventricular / Q000601:surgery*; D014693:Ventricular Fibrillation / Q000601:surgery*